Abstract
Quality of life (QoL) measurement in breast cancer patients who were offered an evaluation at the hereditary cancer unit
Journal of clinical oncology, Vol.24(18_suppl), pp.18532-18532
06/20/2006
DOI: 10.1200/jco.2006.24.18_suppl.18532
Abstract
Abstract only 18532 Background: An Hereditary Cancer Unity was recently established in our service and we aimed to determine how many of our pts with a history of breast cancer would fulfill the criteria for undergoing BRCA1/2 genetic counseling. In addition, we asked whether or not a routine referral for a consultation in this population should impact on QoL. Methods: From September to November 2005, 180 women being followed-up at our service with a history of breast cancer, not in chemotherapy, were invited to schedule a appointment for genetic counseling. 130 pts answered the invitation and were asked to complete QoL questionnaires EORTC QL30 and BR23 (QLQ) validated into Brazilian Portuguese, before and after genetic counseling. Data were analyzed by Wilcoxon test or regression analysis, whatever appropriate, p≤0.05 considered significant. Results: All 130 pts were evaluated and BRCA1/2 mutation risk assessed based on previously published criteria (Frank et al, JCO 20:1480,2002). We evaluated that, as a whole, 25 pts harbor at least 10% probability and 3 were identified that present at least 20% probability. Three additional pts had bilateral cancer. None of these pts had been previously referred to genetic counseling. Regarding EORTC QLQ pre- and post genetic counseling, we found no differences regarding global QoL (75 vs 66), functional scales physical (80 vs 86), role (100 vs 100), cognitive (83 vs 83, social (100 vs 100), sexual function (83 vs 83), sexual pleasure (50 vs 66) or future perspective (33 vs 66) (p > 0.05). Concerning the emotional scale, we found an improvement after counseling (58 vs 75, p = 0.034) which seems to be clinically meaningful. Emotional status and global QoL were positively correlated (p < 0.000, r = 0.473, Pearson correlation). Conclusions: Our impression is that genetic counseling benefit breast cancer pts in terms of QoL, perhaps decreasing emotional distress. Apart from that, we need to define which risk threshold should be adopted in our service. Acknowledgment: to Marcelo Lopes technical assistance. No significant financial relationships to disclose.
Details
- Title: Subtitle
- Quality of life (QoL) measurement in breast cancer patients who were offered an evaluation at the hereditary cancer unit
- Creators
- M. D. Diz - Hospital das Clínicas da Faculdade de Medicina da Universidade de São PauloI. Snitcovsky - Hospital das Clínicas da Faculdade de Medicina da Universidade de São PauloG. F. Almeida - Hospital das Clínicas da Faculdade de Medicina da Universidade de São PauloS. Maistro - Hospital das Clínicas da Faculdade de Medicina da Universidade de São PauloM. H. Federico - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.24(18_suppl), pp.18532-18532
- DOI
- 10.1200/jco.2006.24.18_suppl.18532
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 06/20/2006
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9985152091202771
Metrics
1 Record Views